Bristol Myers Squibb announced on Aug. 10, 2026, the selection of Houston for its new, multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients.
The campus at Generation Park in Houston will create nearly 500 skilled jobs and is designed to grow in scale, capability and workforce for decades to come.
The selection of Houston marks a significant milestone in BMS' $40 billion commitment to invest in the United States over five years across research and development, technology and domestic manufacturing.
“This investment reflects our confidence in America's continued leadership in biopharmaceutical innovation,” said Christopher Boerner, board chair and CEO of Bristol Myers Squibb. “As part of our $40 billion commitment to the United States, we're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure and partnership needed to help bring that vision to life.”
“Texas is a global hub for life sciences, where today's innovations shape the future of health care,” said Texas Gov. Greg Abbott said. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities.”
Bristol Myers Squibb's approximately 600,000-sq.-ft. manufacturing campus will be a modular, multi-modal campus designed for flexibility and long-term growth. Its architecture allows new manufacturing capabilities to be brought online rapidly as pipeline and commercial needs evolve.
The campus is also built for adaptability, with configuration flexibility that anticipates future advances in digital integration and automation, ensuring the site remains at the frontier of biopharmaceutical development and manufacturing technology as capabilities continue to evolve. BMS envisions this site growing in scale and capability well beyond its opening configuration.
BMS selected Texas and Generation Park following an extensive, competitive evaluation of multiple markets in the Central and Eastern U.S. Key factors in this decision included the emerging strength of the local workforce in life sciences, available incentives, proximity to utilities and transportation infrastructure, and an overall business climate conducive to long-term growth.
At 4,300 acres, Generation Park is a curated hub for life sciences and advanced manufacturing. The new BMS campus is projected to employ nearly 500 people initially, with roles spanning operations technicians, production specialists, maintenance and engineering professionals, quality control and assurance experts, and site leadership and administration.
BMS also expects to create approximately 2,000 construction and other indirect jobs between 2027–2030 as the facility is built and brought online, supporting the local economy throughout the construction period.
